Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discovery
Exscientia, the leading Artificial Intelligence (AI)-driven drug discovery company, announced that it has entered a collaboration with Bayer AG that...
